Evelien

Evelien Beuling, Savedalen SE

Patent application number	Description	Published
20090292268	ABSORBENT ARTICLE WITH IMPROVED FIT AND LEAKAGE SECURITY - An absorbent article having front, crotch and rear portions and an absorbent core of unitary construction. The core has a first region with two legs extending in the longitudinal direction of the article through at least parts of the crotch portion towards endings in the rear portion. A maximum distance between facing sides of the legs in the transverse direction is, in the crotch portion, located at a position in the longitudinal direction corresponding to a crotch point. Furthermore, the facing sides of the legs converge backwards such that a distance between them is reduced from the maximum distance to a minimum distance in the rear portion. In addition, the core has a second region surrounding the first region and the average density of the core is lower in the second region than in the first region.	11-26-2009

Patent application number	Description	Published
20100196929	STABILISATION OF THE PHENOTYPIC PROPERTIES OF ISOLATED PRIMARY CELLS - The invention provides a method for stabilisation of phenotypic properties of isolated primary cells comprising modulating at least two epigenetic modifications in said cells.	08-05-2010
20100278782	DIFFERENTIATION OF RAT LIVER EPITHELIAL CELLS INTO HEPATOCYTE-LIKE CELLS - Methods for differentiation of cells of a rat liver epithelial (RLEC) cell line to hepatocyte-like cells are disclosed. In particular, methods involve sequential exposure of the RLEC to two or more differentiation agents. Cells obtained by the method are described as well as their uses in various pharmacological, toxicological, therapeutic, diagnostic and research applications.	11-04-2010

Patent application number	Description	Published
20090325145	METHODOLOGY FOR ANALYSIS OF SEQUENCE VARIATIONS WITHIN THE HCV NS5B GENOMIC REGION - The current invention relates to a standardized method for amplification of an HCV NS5B nucleic acid fragment of any one of HCV genotypes 1 to 6 as a tool for analysis of sequence variations that may be correlated with HCV drug resistance.	12-31-2009
20110136678	METHODOLOGY FOR ANALYSIS OF SEQUENCE VARIATIONS WITHIN THE HCV NS3/4A GENOMIC REGION - The current invention relates to a standardized method for amplification of an HCV NS3/4A or NS3 nucleic acid fragment of any one of HCV genotypes 5 to 6 or HCV genotype 1 as a tool for analysis of sequence variations that may be correlated with 5 HCV drug resistance.	06-09-2011